Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 3, 2013, Pages 460-464

  Bassiouny, Mohamed ^a   Saliba, Walid ^a   Rickard, John ^a   Shao, Mingyuan ^a   Sey, Albert ^a   Diab, Mariam ^a   Martin, David O ^a   Hussein, Ayman ^a   Khoury, Maurice ^a,b   Abi Saleh, Bernard ^b   Alam, Samir ^b   Sengupta, Jay ^a   Borek, P Peter ^a   Baranowski, Bryan ^a   Niebauer, Mark ^a   Callahan, Thomas ^a   Varma, Niraj ^a   Chung, Mina ^a   Tchou, Patrick J ^a   Kanj, Mohamed ^a,b   Dresing, Thomas ^a   Lindsay, Bruce D ^a   Wazni, Oussama ^a,b   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Ablation; Anticoagulants; Catheter ablation; Fibrillation; Stroke

Indexed keywords

DABIGATRAN ETEXILATE; WARFARIN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN; DRUG DERIVATIVE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATAXIC APHASIA; BLEEDING; BLOOD CLOTTING TIME; BRAIN HEMORRHAGE; CATHETER ABLATION; DRUG WITHDRAWAL; FALSE ANEURYSM; FEMALE; FOLLOW UP; GROIN HEMATOMA; HEART ATRIUM FIBRILLATION; HEMOPTYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPENSITY SCORE; PULMONARY VEIN ISOLATION; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ABLATION; AGED; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; FIBRILLATION; FIBRINOLYTIC THERAPY; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ABLATION; ANTICOAGULANTS; CATHETER ABLATION; FIBRILLATION; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; WARFARIN;

EID: 84882251208     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000320     Document Type: Article

References (18)

1. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clémenty J. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101:1409-1417.
2. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634-2640.
3. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38.
4. Dorbala S, Cohen AJ, Hutchinson LA, Menchavez-Tan E, Steinberg JS. Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study. J Cardiovasc Electrophysiol. 1998;9:1152-1160.
5. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Nayak HM, Hsia HH. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005;16:474-477.
6. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F Jr, Jongnarangsin K, Bogun F, Morady F. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006;114:759-765.
7. Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116:2531-2534.
8. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121:2550-2556.
9. Kwak JJ, Pak HN, Jang JK, Kim SK, Park JH, Choi JI, Hwang C, Kim YH. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:620-625.
10. Calkins H, Kuck K H, Cappato R, Brugada J, Camm A J, Chen S, Crijns H J.G., Damiano R J, Davies D W, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz M. D., Haines D. E., Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim Y H, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay B D, Mansour M, Marchlinski F E, McCarthy P M, Mont J L, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer D L, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin J N, Shemin R J, Tsao H M, Wilber D. 2012 HRS/ EHRA/ECAS Expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9:632-696.
11. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
12. Kanj MH, Wazni OM, Natale A. How to do circular mapping catheterguided pulmonary vein antrum isolation: the Cleveland Clinic approach. Heart Rhythm. 2006;3:866-869.
13. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134:1128-1135.
14. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387-398.
15. Agresti A, Min Y. Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med. 2004;23:65-75.
16. Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol. 2012;59:1168-1174.
17. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-2372.
18. Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol. 2002;13:764-767.